Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -43.91%4.9B | ---- | 58.60%8.74B | ---- | -48.72%5.51B | ---- | 55.36%10.75B | ---- | -22.33%6.92B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 0.14%-694.7M | ---- | -48.21%-695.67M | ---- | -10.88%-469.39M | ---- | 11.41%-423.33M | ---- | 11.54%-477.88M |
| Dividend (income)- adjustment | ---- | 22.71%-8.04M | ---- | -15.04%-10.41M | ---- | 81.11%-9.05M | ---- | -367.48%-47.88M | ---- | 66.63%-10.24M |
| Attributable subsidiary (profit) loss | ---- | 34.37%-510M | ---- | -79.92%-777.06M | ---- | 37.02%-431.89M | ---- | 15.11%-685.81M | ---- | -64.27%-807.92M |
| Impairment and provisions: | ---- | 17.88%1.7B | ---- | 1,731.92%1.44B | ---- | -97.81%78.86M | ---- | 484.95%3.6B | ---- | 93.16%615.48M |
| -Impairment of property, plant and equipment (reversal) | ---- | -24.03%935.68M | ---- | 4,765.23%1.23B | ---- | -103.00%-26.4M | ---- | 3,602.39%878.91M | ---- | -91.83%23.74M |
| -Impairmen of inventory (reversal) | ---- | 23.12%39.88M | ---- | 724.91%32.39M | ---- | 61.44%-5.18M | ---- | -766.54%-13.44M | ---- | 64.36%-1.55M |
| -Impairment of trade receivables (reversal) | ---- | 3,859.38%70.48M | ---- | -93.86%1.78M | ---- | -88.59%28.97M | ---- | 152.19%253.82M | ---- | 248.90%100.65M |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 233.17%265.05M | ---- | 411.05%79.56M |
| -Other impairments and provisions | ---- | 267.24%656.85M | ---- | 119.54%178.86M | ---- | -96.32%81.47M | ---- | 436.42%2.22B | ---- | 3,527.28%413.09M |
| Revaluation surplus: | ---- | 1,164.49%788.27M | ---- | -167.02%-74.05M | ---- | 114.20%110.49M | ---- | -857.83%-777.95M | ---- | 137.68%102.66M |
| -Fair value of investment properties (increase) | ---- | 869.02%779.48M | ---- | -894.12%-101.36M | ---- | 98.84%-10.2M | ---- | -572.10%-877.97M | ---- | 183.84%185.97M |
| -Other fair value changes | ---- | -67.80%8.79M | ---- | -77.37%27.31M | ---- | 20.66%120.68M | ---- | 220.05%100.02M | ---- | -64.46%-83.32M |
| Asset sale loss (gain): | ---- | -429.50%-1.35B | ---- | -206.49%-254.99M | ---- | 114.35%239.45M | ---- | -129.17%-1.67B | ---- | -12,970.44%-728.15M |
| -Loss (gain) from sale of subsidiary company | ---- | -428.95%-1.35B | ---- | -205.39%-254.98M | ---- | 117.83%241.94M | ---- | -87.52%-1.36B | ---- | ---723.76M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -41,600.00%-1.25M | ---- | 99.88%-3K | ---- | 99.20%-2.49M | ---- | -6,986.76%-311.53M | ---- | 21.09%-4.4M |
| -Loss (gain) from selling other assets | ---- | ---183K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | 19.18%2.02B | ---- | 12.34%1.69B | ---- | -12.39%1.51B | ---- | 5.84%1.72B | ---- | -7.81%1.62B |
| -Amortization of intangible assets | ---- | 21.84%1.37B | ---- | 20.25%1.13B | ---- | -16.08%936.4M | ---- | 11.04%1.12B | ---- | -13.04%1B |
| Financial expense | ---- | -13.18%2.03B | ---- | 24.94%2.33B | ---- | 11.00%1.87B | ---- | -9.31%1.68B | ---- | -2.18%1.85B |
| Special items | ---- | -7.94%-437.75M | ---- | -39.62%-405.53M | ---- | -490.20%-290.45M | ---- | -149.11%-49.21M | ---- | --100.21M |
| Operating profit before the change of operating capital | ---- | -29.67%8.43B | ---- | 47.83%11.99B | ---- | -42.45%8.11B | ---- | 53.37%14.09B | ---- | -20.38%9.19B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 172.20%6.8B | ---- | 85.07%2.5B | ---- | 156.82%1.35B | ---- | 151.71%525.65M | ---- | 53.24%-1.02B |
| Accounts receivable (increase)decrease | ---- | -89.89%33.76M | ---- | 104.37%333.89M | ---- | -560.22%-7.65B | ---- | 140.19%1.66B | ---- | -21.45%-4.13B |
| Accounts payable increase (decrease) | ---- | -74.88%134.78M | ---- | -92.25%536.48M | ---- | 471.75%6.93B | ---- | -287.85%-1.86B | ---- | -59.41%991.67M |
| prepayments (increase)decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---3.47B | ---- | ---- |
| Financial assets at fair value (increase)decrease | ---- | 100.48%7.85M | ---- | -8,465.12%-1.63B | ---- | -83.86%19.51M | ---- | -53.77%120.91M | ---- | 94.11%261.55M |
| Special items for working capital changes | ---- | -3.38%-6.93B | ---- | -91.42%-6.71B | ---- | -251.41%-3.5B | ---- | -60.58%2.31B | ---- | 6,249.76%5.87B |
| Cash from business operations | ---- | 20.74%8.48B | ---- | 33.59%7.02B | ---- | -60.72%5.26B | ---- | 19.88%13.38B | ---- | 29.28%11.16B |
| Hong Kong profits tax paid | ---- | 45.50%-21.98M | ---- | 63.62%-40.32M | ---- | -295.02%-110.86M | ---- | 85.88%-28.06M | ---- | -304.92%-198.71M |
| China income tax paid | ---- | -38.92%-3.64B | ---- | 43.47%-2.62B | ---- | -22.13%-4.63B | ---- | 5.05%-3.79B | ---- | -7.98%-4B |
| Other taxs | ---- | 52.22%-3.02M | ---- | -144.73%-6.33M | ---- | --14.14M | ---- | ---- | ---- | ---- |
| Special items of business | 3.85%-806.51M | ---- | -146.40%-838.76M | ---- | 122.42%1.81B | ---- | -378.66%-8.06B | ---- | 308.82%2.89B | ---- |
| Net cash from operations | 3.85%-806.51M | 10.52%4.81B | -146.40%-838.76M | 727.65%4.35B | 122.42%1.81B | -94.50%526.18M | -378.66%-8.06B | 37.19%9.56B | 308.82%2.89B | 42.65%6.97B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -13.53%286.86M | 5.61%731.67M | 21.03%331.74M | 50.65%692.79M | 39.21%274.09M | 8.15%459.86M | 9.85%196.89M | -11.38%425.19M | -21.00%179.24M | -10.52%479.8M |
| Dividend received - investment | -57.37%143.2M | 37.09%376.19M | 286.18%335.91M | -12.87%274.41M | -80.24%86.98M | -50.12%314.94M | 193.33%440.14M | 127.42%631.41M | -9.56%150.05M | -11.80%277.63M |
| Loan receivable (increase) decrease | -122.17%-62.16M | 1,108.35%685.61M | 273.51%280.43M | -105.41%-67.99M | -301.19%-161.62M | 254.83%1.26B | -101.79%-40.29M | 45.91%-812.27M | 497.72%2.26B | -306.11%-1.5B |
| Decrease in deposits (increase) | 1,228.12%3.49B | -827.45%-5.11B | -80.57%262.44M | 14.03%-550.61M | 127.69%1.35B | -49.31%-640.44M | 4,071.78%593.19M | -191.00%-428.92M | -104.03%-14.94M | 205.09%471.34M |
| Sale of fixed assets | 126.35%29.32M | -35.52%7.29M | 30.27%12.96M | -74.01%11.3M | -8.44%9.95M | -93.14%43.49M | 95.82%10.86M | 650.16%634M | --5.55M | -5.65%84.52M |
| Purchase of fixed assets | -18.20%-276.53M | 65.61%-454.86M | -48.18%-233.96M | -144.67%-1.32B | 25.08%-157.89M | 23.92%-540.52M | 36.02%-210.75M | -131.66%-710.45M | 20.60%-329.4M | 41.58%-306.68M |
| Selling intangible assets | --409.9M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Purchase of intangible assets | 45.59%-383.07M | -33.23%-3.4B | 46.71%-704.03M | -1,393.35%-2.55B | -226.35%-1.32B | 97.32%-171.07M | -77.84%-404.85M | -127.06%-6.37B | 1.97%-227.64M | -149.02%-2.81B |
| Sale of subsidiaries | 1,604.73%2.46B | 517.04%2.22B | -59.83%144.26M | 157.50%359.11M | --359.11M | -97.05%139.46M | ---- | 333.67%4.73B | -71.31%142.56M | 506.12%1.09B |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | -521.27%-565.75M | 94.97%-291.35M | 126.57%134.3M | -3,354.76%-5.79B | -107.24%-505.49M |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --513.77M | 445.34%707.55M | ---- |
| Cash on investment | ---8.06M | -129.30%-2.04B | ---- | 75.71%-888.81M | -35.73%-56.57M | -171.79%-3.66B | 90.35%-41.68M | 39.30%-1.35B | 74.32%-431.91M | -663.42%-2.22B |
| Other items in the investment business | 2,297.55%1.64B | 624.39%68.98M | --68.28M | -96.73%9.52M | ---- | 1,404.54%291.49M | ---- | -56.55%19.37M | 41.63%19.29M | -85.92%44.59M |
| Net cash from investment operations | 1,450.38%7.72B | -71.33%-6.92B | 29.88%498.02M | -31.49%-4.04B | 52.06%383.45M | -19.15%-3.07B | 107.57%252.17M | 47.28%-2.58B | -100.63%-3.33B | -214.75%-4.89B |
| Net cash before financing | 2,129.27%6.91B | -762.70%-2.1B | -115.55%-340.75M | 112.48%317.51M | 128.06%2.19B | -136.44%-2.54B | -1,683.89%-7.81B | 235.74%6.98B | 85.63%-437.83M | -37.57%2.08B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -7.50%8.34B | 80.01%26.32B | 13.47%9.02B | -45.06%14.62B | -48.82%7.95B | 16.69%26.61B | 21.69%15.53B | -16.29%22.81B | -29.85%12.76B | 24.66%27.24B |
| Refund | -66.79%-10.79B | -67.58%-23.71B | 5.68%-6.47B | 46.31%-14.15B | 23.02%-6.86B | -81.43%-26.36B | -16.45%-8.91B | 46.27%-14.53B | 56.34%-7.65B | -52.68%-27.04B |
| Issuance of bonds | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.1B |
| Interest paid - financing | 20.46%-915.8M | 9.13%-2.37B | 15.52%-1.15B | 7.85%-2.61B | -71.77%-1.36B | -9.63%-2.83B | -11.90%-793.51M | 12.45%-2.58B | 21.52%-709.16M | -0.41%-2.95B |
| Dividends paid - financing | 1.34%-692.82M | -7.83%-1.54B | 25.62%-702.2M | 37.58%-1.42B | -49.81%-944.03M | -49.48%-2.28B | 24.75%-630.14M | -1.41%-1.53B | 19.23%-837.38M | -48.09%-1.5B |
| Absorb investment income | --3.34M | -99.80%1.08M | ---- | 37.72%553.75M | -88.71%18.1M | 281.73%402.09M | 430.21%160.28M | -60.53%105.33M | -14.79%30.23M | -19.93%266.86M |
| Issuance expenses and redemption of securities expenses | ---- | -196.30%-3.92M | 0.36%-3.92M | -36.64%-1.32M | -30.84%-3.94M | 99.92%-969K | 90.82%-3.01M | ---1.24B | ---32.76M | ---- |
| Other items of the financing business | ---689K | ---- | ---- | ---248.56M | ---576.34M | ---- | ---- | ---- | ---- | -87.47%-148.07M |
| Net cash from financing operations | -735.43%-4.1B | 58.71%-1.38B | 135.37%644.96M | 26.70%-3.34B | -134.34%-1.82B | -256.49%-4.56B | 51.76%5.31B | 192.63%2.91B | 1,704.02%3.5B | -989.16%-3.15B |
| Effect of rate | 174.64%528.2M | -45.10%-898.97M | 43.53%-707.7M | 71.51%-619.54M | 32.76%-1.25B | -2,045.03%-2.17B | -569.61%-1.86B | -106.69%-101.38M | 183.99%396.85M | 266.04%1.52B |
| Net Cash | 825.78%2.82B | -15.17%-3.48B | -17.26%304.22M | 57.42%-3.03B | 114.70%367.67M | -171.79%-7.1B | -181.68%-2.5B | 1,027.99%9.9B | 193.78%3.06B | -128.94%-1.07B |
| Begining period cash | -17.38%20.84B | -12.63%25.23B | -12.63%25.23B | -24.32%28.87B | -24.33%28.87B | 34.55%38.15B | 34.56%38.15B | 1.61%28.35B | 1.61%28.35B | 11.03%27.9B |
| Cash at the end | -2.56%24.19B | -17.38%20.84B | -11.30%24.82B | -12.63%25.23B | -17.18%27.98B | -24.32%28.87B | 6.21%33.79B | 34.55%38.15B | 31.63%31.81B | 1.61%28.35B |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --31.81B | ---- |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --31.81B | ---- |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Touche Tohmatsu CPA LLP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.